Condensed Consolidated Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 2,551,870 | $ 3,662,615 |
Other receivable | ||
Other assets | 251,751 | 43,391 |
Total current assets | 2,803,621 | 3,706,006 |
Long-term assets | ||
Security deposit | 17,004 | 17,004 |
Property and equipment - net | 207,056 | 206,810 |
Deferred compensation | 208,333 | 416,666 |
Right of use asset - operating | 516,948 | 544,670 |
Total long-term assets | 949,341 | 1,185,150 |
Total assets | 3,752,962 | 4,891,156 |
Current liabilities | ||
Accounts payable | 140,939 | 195,381 |
Notes payable | 1,175,435 | 1,000,001 |
Notes payable CARES Act PPP Loan | 6,770 | 24,189 |
Due to related parties | 50,000 | 50,000 |
Operating lease liability - current | 85,666 | 76,227 |
Accrued expenses | 19,609 | 21,870 |
Accrued dividends | 48,079 | 48,079 |
Total current liabilities | 1,526,499 | 1,415,747 |
Long-term liabilities | ||
Operating lease liability - non-current | 484,556 | 507,188 |
Total long-term assets | 484,556 | 507,188 |
Total liabilities | 2,011,055 | 1,922,935 |
Stockholders’ Equity | ||
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at March 31, 2022 and December 31, 2021 (Liquidation preference $340,050 and $340,050, respectively) | 14 | 14 |
Common stock, $.001 par value, 500,000,000 shares authorized; 207,692,878 and 207,562,461 shares issued and outstanding at March 31, 2022 and at December 31, 2021, respectively | 207,692 | 207,562 |
Additional paid-in capital | 101,007,609 | 100,452,862 |
Accumulated deficit | (99,473,407) | (97,692,217) |
Total stockholders’ equity | 1,741,908 | 2,968,221 |
Total Liabilities and Stockholders’ Equity | $ 3,752,962 | $ 4,891,156 |